358 related articles for article (PubMed ID: 27999621)
41. Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study.
Liu Y; Tham CK; Ong SY; Ho KS; Lim JF; Chew MH; Lim CK; Zhao Y; Tang CL; Eu KW
Biomarkers; 2013 Aug; 18(5):399-405. PubMed ID: 23862763
[TBL] [Abstract][Full Text] [Related]
42.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
43. Comparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancer.
Danese E; Minicozzi AM; Benati M; Montagnana M; Paviati E; Salvagno GL; Lima-Oliveira G; Gusella M; Pasini F; Lippi G; Guidi GC
PLoS One; 2015; 10(5):e0126417. PubMed ID: 25946211
[TBL] [Abstract][Full Text] [Related]
44. Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.
Ørntoft MB; Nielsen HJ; Ørntoft TF; Andersen CL;
BMC Cancer; 2015 Oct; 15():819. PubMed ID: 26514170
[TBL] [Abstract][Full Text] [Related]
45. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.
Ilse P; Biesterfeld S; Pomjanski N; Wrobel C; Schramm M
Cancer Genomics Proteomics; 2014; 11(5):251-8. PubMed ID: 25331797
[TBL] [Abstract][Full Text] [Related]
46. A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer.
Stubendorff B; Wilhelm K; Posselt K; Catto J; Hartmann A; Bertz S; Füssel S; Novotny V; Toma M; Gajda M; Lehmann J; Wunderlich H; Grimm MO; Stöckle M; Junker K
J Cancer Res Clin Oncol; 2019 Apr; 145(4):811-820. PubMed ID: 30603903
[TBL] [Abstract][Full Text] [Related]
47. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.
Connolly D; Yang Z; Castaldi M; Simmons N; Oktay MH; Coniglio S; Fazzari MJ; Verdier-Pinard P; Montagna C
Breast Cancer Res; 2011 Aug; 13(4):R76. PubMed ID: 21831286
[TBL] [Abstract][Full Text] [Related]
48. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
49. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
[TBL] [Abstract][Full Text] [Related]
50. DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma.
Li Q; Chen C; Ren X; Sun W
Oncotarget; 2017 May; 8(20):33100-33109. PubMed ID: 28380439
[TBL] [Abstract][Full Text] [Related]
51. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
[TBL] [Abstract][Full Text] [Related]
52. SEPT9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt/β-catenin signaling pathway via miR92b-3p/FZD10 in nasopharyngeal carcinoma cells.
Jiang Y; Liu L; Xiang Q; He X; Wang Y; Zhou D; Zou C; Chen Q; Peng M; He J; Jiang X; Xiang T; Yang Y
Clin Epigenetics; 2020 Mar; 12(1):41. PubMed ID: 32138771
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules.
Ji XY; Li H; Chen HH; Lin J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8557-8571. PubMed ID: 37097393
[TBL] [Abstract][Full Text] [Related]
54. HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples.
Loi E; Zavattari C; Tommasi A; Moi L; Canale M; Po A; Sabato C; Vega-Benedetti AF; Ziranu P; Puzzoni M; Lai E; Faloppi L; Rullán M; Carrascosa J; Amat I; Urman JM; Arechederra M; Berasain C; Ferretti E; Casadei-Gardini A; Avila MA; Alonso S; Scartozzi M; Zavattari P
Br J Cancer; 2022 Jun; 126(12):1783-1794. PubMed ID: 35177798
[TBL] [Abstract][Full Text] [Related]
55. Promoter hypermethylation of SLIT2 is a risk factor and potential diagnostic biomarker for nasopharyngeal carcinoma.
Li J; Zhou C; Wang G; Wang S; Ni S; Ye M; Zhang J
Gene; 2018 Feb; 644():74-79. PubMed ID: 29107007
[TBL] [Abstract][Full Text] [Related]
56. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
Payne SR
Epigenomics; 2010 Aug; 2(4):575-85. PubMed ID: 22121975
[TBL] [Abstract][Full Text] [Related]
57. Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma.
Chang YT; Hsu C; Jeng YM; Chang MC; Wei SC; Wong JM
J Gastroenterol Hepatol; 2007 Mar; 22(3):389-94. PubMed ID: 17295772
[TBL] [Abstract][Full Text] [Related]
58. Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening.
Wu D; Zhou G; Jin P; Zhu J; Li S; Wu Q; Wang G; Sheng J; Wang J; Song L; Han X; Qian J
J Mol Diagn; 2016 Jul; 18(4):535-45. PubMed ID: 27133379
[TBL] [Abstract][Full Text] [Related]
59. A First Step to a Biomarker of Curative Surgery in Colorectal Cancer by Liquid Biopsy of Methylated Septin 9 Gene.
Leon Arellano M; García-Arranz M; Ruiz R; Olivera R; Magallares S; Olmedillas-Lopez S; Valdes-Sanchez T; Guadalajara H; García-Olmo D
Dis Markers; 2020; 2020():9761406. PubMed ID: 32566042
[TBL] [Abstract][Full Text] [Related]
60. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
